Shayan Imran

Shayan Imran

Auto-generated profile, based on publicly available information

Shayan Imran

IRD Pakistan, Karachi, Pakistan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2021 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Closed access
AKAnokhi Ali Khan
Anokhi Ali Khan
MMMehr Munir
Mehr Munir
FMFatima Miraj
Fatima Miraj
SIShayan Imran
Shayan Imran
DSDanya Arif Siddiqi
Danya Arif Siddiqi
SCSubhash Chandir
Subhash Chandir
Auto-disable (AD) syringes are specifically designed to prevent syringe reuse. However, the notion that specific AD syringe designs may be unsafe due to reuse concerns related to the syringe’s activation point has surfaced. We conducted a systematic review for evidence on the association between AD syringe design and syringe reuse, adverse events following immunization (AEFI), or blood borne virus (BBV) transmission. We found no evidence of an association between AD syringe design and unsafe injection practices including syringe reuse, AEFIs, or BBVs. Authors of three records speculated about the possibility of AD syringe reuse through intentionally defeating the disabling mechanism, and one hinted at the possibility of reuse of larger-than-required syringes, but none reported any actual reuse instance. In contrast to AD syringes, standard disposable syringes continue to be reused; therefore, the global health community should expand the use of AD syringes in both immunization and therapeutic context as an essential strategy for curbing BBV transmission.